Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Cooper

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Systematic Reviews|August 15, 2024
Prevalence of human filovirus infections in sub-Saharan Africa: A systematic review and meta-analysis protocolChristopher S Semancik, Christopher L Cooper, Thomas S Postler, et al.
Ebiomedicine|February 13, 2016
Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityKaren A O Martins, Christopher L Cooper, Sabrina M Stronsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2016
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single doseJasdave S Chahal, Omar F Khan, Christopher L Cooper, et al.
Vaccines|January 8, 2025
Seroprevalence of Antibodies to Filoviruses with Outbreak Potential in Sub-Saharan Africa: A Systematic Review to Inform Vaccine Development and DeploymentChristopher S Semancik, Hilary S Whitworth, Matt A Price, et al.
Research in Developmental Disabilities|November 19, 2003
The development and factor structure of the Functional Assessment for multiple causaliTy (FACT)Johnny L Matson, David E Kuhn, Dennis R Dixon, et al.
Iscience|April 7, 2020
Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus InfectionYangsheng Yu, Christopher L Cooper, Guangshun Wang, et al.
Viral Immunology|December 17, 2014
Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoproteinKaren Martins, John H Carra, Christopher L Cooper, et al.
Viruses|October 29, 2025
An Intranasal Challenge Model in African Green Monkeys (<i>Chlorocebus aethiops</i>) for Mild-to-Moderate COVID-19 Disease Caused by Subvariant XBB.1.5Nadia Storm, Ming Lo, Nicholas Crossland, et al.
Plos Pathogens|April 1, 2016
siRNA Screen Identifies Trafficking Host Factors that Modulate Alphavirus InfectionSheli R Radoshitzky, Gianluca Pegoraro, Xi Olì Chī, et al.
Vaccines|October 27, 2022
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical TrialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Systematic Reviews|August 15, 2024
Prevalence of human filovirus infections in sub-Saharan Africa: A systematic review and meta-analysis protocolChristopher S Semancik, Christopher L Cooper, Thomas S Postler, et al.
Ebiomedicine|February 13, 2016
Adjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityKaren A O Martins, Christopher L Cooper, Sabrina M Stronsky, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2016
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single doseJasdave S Chahal, Omar F Khan, Christopher L Cooper, et al.
Vaccines|January 8, 2025
Seroprevalence of Antibodies to Filoviruses with Outbreak Potential in Sub-Saharan Africa: A Systematic Review to Inform Vaccine Development and DeploymentChristopher S Semancik, Hilary S Whitworth, Matt A Price, et al.
Research in Developmental Disabilities|November 19, 2003
The development and factor structure of the Functional Assessment for multiple causaliTy (FACT)Johnny L Matson, David E Kuhn, Dennis R Dixon, et al.
Iscience|April 7, 2020
Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus InfectionYangsheng Yu, Christopher L Cooper, Guangshun Wang, et al.
Viral Immunology|December 17, 2014
Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoproteinKaren Martins, John H Carra, Christopher L Cooper, et al.
Viruses|October 29, 2025
An Intranasal Challenge Model in African Green Monkeys (<i>Chlorocebus aethiops</i>) for Mild-to-Moderate COVID-19 Disease Caused by Subvariant XBB.1.5Nadia Storm, Ming Lo, Nicholas Crossland, et al.
Plos Pathogens|April 1, 2016
siRNA Screen Identifies Trafficking Host Factors that Modulate Alphavirus InfectionSheli R Radoshitzky, Gianluca Pegoraro, Xi Olì Chī, et al.
Vaccines|October 27, 2022
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical TrialsChristopher L Cooper, Gavin Morrow, Maoli Yuan, et al.
Pageof 4